• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » UPDATE: Facet Solutions releases Acadia trial results, raises $2.1 million

UPDATE: Facet Solutions releases Acadia trial results, raises $2.1 million

April 23, 2010 By MassDevice staff

Facet Solutions logo

Facet Solutions Inc. finished compiling two-year data from a Phase III clinical trial of its Acadia spinal implant, saying the patients experienced less leg and back pain and improved mobility two years after the procedure.

The Hopkinton, Mass.-based company also drummed up $2.1 million in an offering of debt, options, warrants or other securities to a group of 43 investors, according to a filing with the federal Securities & Exchange Commission.

Facet Solutions’ Acadia device is designed to treat lumbar spinal stenosis, a condition in which the facet joints of the lumbar spine wear down and impinge on spinal nerves. The standard surgical treatment is decompression with spinal fusion, in which doctors trim or remove the facet bones to relieve the impingement. Because the facet bones help provide stability to the vertebrae, surgeons then use an implant to fuse adjacent vertebrae.

The Acadia device is designed to restore the range of motion following decompression surgery by replacing the facet joints with an antomically designed implant, according to the company’s website.

The clinical trial of the device, slated to enroll 300 patients, examined physical function and severity of symptoms for 24 months after implantation. Two-thirds of the patients in the study received the Acadia implant, while the remainder underwent traditional decompression and fusion surgery.

Facet Solutions said patients in the study showed "significant and sustained improvement" in leg and back pain, measured using the visual analogue scale via questionnaire. Patients also showed "sustained improvement" in Oswestry Disability Index, a questionnaire-based measure of permanent functional disability.

"There were no re-operations in any of the patients, and all patients met the definition of success for ODI improvement," according to a press release.

Dr. James Youssef, a principal investigator for the study at SpineColorado in Durango, Colo., is scheduled to present a clinical update on the trial at the Spine Arthroplasty Society’s meeting in New Orleans April 30.

Facet Solutions president and CEO Geoff Pardo did not immediately return a call seeking comment.

Filed Under: Business/Financial News, News Well, Orthopedics, Spine Tagged With: Facet Solutions Inc.

More recent news

  • Vicarious Surgical inks surgical robot collab with hospital, eyes first clinical patients
  • Bioliberty launches hub for soft-robotic wearable devices
  • Zynex submits laser pulse oximeter to FDA
  • Roche invests $550M to make Indianapolis a CGM manufacturing hub
  • Product liability lawsuits target Medtronic, Boston Scientific spinal cord stim tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy